PhoenixBio Co Ltd (6190)

Currency in JPY
427.0
-23.0(-5.11%)
Closed·

6190 Financial Summary

Key Ratios

P/E Ratio-4.06
Price/Book1.34
Debt / Equity41.35%
Return on Equity-28.35%
Dividend Yield0.00%
EBITDA-108.00M
Fair ValueUnlock
Fair Value UpsideUnlock

Statements Highlights

Period Ending:
2016
31/03
2017
31/03
2018
31/03
2019
31/03
2020
31/03
2021
31/03
2022
31/03
2023
31/03
2024
31/03
2025
31/03
* In Millions of JPY (except for per share items)

Earnings

Latest Release
May 15, 2025
EPS / Forecast
-72.89 / --
Revenue / Forecast
398.00M / --
EPS Revisions
Last 90 days

FAQ

What were PhoenixBio Co's earnings for the latest quarter?

The PhoenixBio Co EPS (TTM) is -110.76. PhoenixBio Co reported sales of 398.00, net income of -298.00, and EPS of -72.89 for the latest quarter.

What was PhoenixBio Co's net income for the latest quarter?

PhoenixBio Co's net income for the latest quarter was -298.00.

How did PhoenixBio Co's performance compare year-over-year in the latest quarter?

The company's revenue moved from 355.00 in the previous quarter to 398.00 in the latest quarter, and net income moved from -26.00 to -298.00 compared to the previous quarter.

What is PhoenixBio Co's net profit margin on a TTM basis?

PhoenixBio Co's trailing twelve months (TTM) net profit margin is -29.07%.

How does PhoenixBio Co's debt to equity ratio compare to industry standards?

PhoenixBio Co's total debt-to-equity ratio is 41.35%.

What is PhoenixBio Co's return on investment on a TTM basis?

PhoenixBio Co's trailing twelve months (TTM) return on investment (ROI) is -28.35%.

What were PhoenixBio Co's total assets and liabilities in the latest quarter?

As of the latest quarter, PhoenixBio Co reported total assets of 2,285.00 million and total liabilities of 566.00 million.

How has PhoenixBio Co's total revenue grown this year?

PhoenixBio Co's total revenue was 355.00 in the previous quarter and 398.00 in the latest quarter.

What is PhoenixBio Co's gross margin on a TTM basis?

PhoenixBio Co's trailing twelve months (TTM) gross margin is 72.49%.

What was PhoenixBio Co's revenue per share for the latest quarter?

PhoenixBio Co's revenue per share for the latest quarter was 298.59.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.